The Global Liver Disease Treatment Market Size Was Worth USD 21.43 Billion In 2022 And Is Estimated To Grow To USD 33.14 Billion By 2030, With A CAGR Of Approximately 5.6 % Over The Forecast Period From 2023 To 2030.
Liver Disease Treatment Market Overview
The liver is a crucial organ of the body that carries out important tasks like storing vitamins and nutrients, purging unwanted compounds from the blood, and preserving a proper chemical equilibrium in the body. Common liver ailments include cancer, hepatitis, autoimmune conditions, and genetic problems. Infections, heredity, obesity, diabetes, and immune system anomalies are the major causes of these illnesses. Vaccines, chemotherapy, antiviral medications, immunoglobulins, corticosteroids, and immunosuppressants are a few of the often utilized therapeutic approaches for liver illnesses. Treatment for liver disease aids in hormone and cholesterol excretion boosts bile synthesis and activates enzymes. The market is expected to rise due to the rising prevalence of fatty liver disease brought on by excessive cholesterol, obesity, hypertension, and diabetes. Additionally, several technological developments, such as the creation of the bioartificial liver, are accelerating market expansion. The quick uptake of antiviral medications is positively impacting the market growth due to their safety and efficacy, ability to suppress the hepatitis B virus, and ability to lower the risk of developing cirrhosis and hepatocellular carcinoma. A good picture of the market is also being created by rising research and development (R&D) efforts, significant healthcare sector growth, and numerous government initiatives to promote public health.
Market Drivers:
The excessive buildup of extra fat in the liver is a condition known as liver disease, particularly non-alcoholic fatty liver disease (NAFLD). In developing nations like India and China, NAFLD is becoming recognized as the primary contributor to chronic liver disease. As a result, government agencies are developing creative and appealing programs to combat liver illnesses. For instance, the Indian government stated in February 2021 that NAFLD would be incorporated into the National Program for Prevention & Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS). This program primarily focuses on several issues, such as the early diagnosis and management of NAFLD and the development of a healthcare system for the prevention, detection, and treatment of NAFLD. Such government actions could boost the market for treating liver disease within the anticipated time frame.
Restraints
The requirement for substantial expenditure in drug development may constrain the analysis period’s expansion of the global liver disease treatment market. In addition, strict government regulations by the U.S. Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency (MHRA), as well as the side effects connected with medications, are some of the factors impeding the growth of the global market.
Liver Disease Treatment Market: Segmentation
The global liver disease treatment market is segregated based on treatment type and disease type.
- Based on treatment type, the market is divided into antiviral drugs, immunosuppressants, vaccines, immunoglobulins, corticosteroids, targeted therapy, and chemotherapy. Among these, the antiviral drugs category led the market in 2021 and is expected to maintain its dominance throughout the forecast period. The antiviral drug sub-segment is benefiting from the significantly increasing investments in the field of antiviral pharmaceuticals, which is mostly due to its great benefits. The rise in healthcare spending increased public awareness, and the rising prevalence of hepatitis B and C are key factors expected to support market expansion. In addition, major industry participants are developing fresh technologies to expand their position globally.
- Based on disease type, the market is divided into hepatitis, autoimmune diseases, non-alcoholic fatty liver disease (NAFLD), cancer, and genetic disorders. The non-alcoholic fatty liver disease (NAFLD) category dominated the market in 2021. Some key drivers driving the sub-segment growth include the massive rise in obesity prevalence worldwide, liver disease awareness in developing nations, diabetes, and considerable R&D spending. Furthermore, the National Diabetes Statistics Report, 2020, issued by the CDC, states that roughly 34.2 million Americans have diabetes (10.5% of the US population), making it the seventh greatest cause of death in the nation. These crucial factors are also projected to fuel the market for NAFLD drugs.
Liver Disease Treatment Market: Regional Landscape
In 2022, the Asia Pacific dominated the market for liver disease treatment. The necessity for new healthcare infrastructure, increasing hepatitis cases, and hepatocellular carcinoma fuel market growth. Due to acceptable government actions regarding lowering medical costs and developing new drugs to treat liver disease, Japan and Australia are promoting the market growth. Market expansion in the area is fueled by the elements above. In India, around 10 lakh people receive a new diagnosis of liver cirrhosis each year. The rise in the number of people with diabetes and obese people in India has doubled in market growth.
COVID-19 Impact:
The COVID-19 outbreak is expected to have a moderate impact because of the fall in demand for certain medications used in liver treatments. Limited access to medical treatment, a staffing crisis in the healthcare industry, an increase in the number of hospitalizations connected to COVID-19, and the availability of medications and vaccines are additional issues that impact the market. However, as COVID-19 immunizations become available, several countries are attempting to guarantee an uninterrupted supply of medicines and vaccines that can save lives. As a result, it is anticipated that this will eventually cause the market to stabilize. On the other hand, research projects and initiatives by different researchers, businesses, and the government, including clinical trials for the efficacy and safety of the treatment of liver illness, increased the market for liver disease treatments.
Liver Disease Treatment Market: Competitive Landscape
Some of the main competitors dominating the global liver disease treatment market include– ABBVIE INC., ABBOTT LABORATORIES, ASTELLAS PHARMA INC., BRISTOL-MYERS SQUIBB, ELI LILLY AND COMPANY, EMERGENT BIOSOLUTIONS INC. (CANGENE BIOPHARMA), F. HOFFMANN-LA ROCHE AG, GILEAD SCIENCES, INC., MERCK & CO. INC, and VIATRIS INC.
Recent Developments:
- January 2022: A partnership between Novartis and Alnylam was announced to research targeted therapies to improve liver function. They have decided to collaborate on the research and development of siRNA-based targeted therapeutics to regenerate functional liver cells in patients with advanced liver disease. The collaboration intends to develop liver-targeted therapy as an alternative to transplantation for patients with liver failure.
- January 2019: For treating non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis, SciCann Therapeutics established a liver disease program at Tel Aviv University. The program’s main goal was to examine the effectiveness of SciCann’s line of proprietary, cannabinoid-based, anti-inflammatory combination products (NASH)
The Global Liver Disease Treatment Market is segmented as follows:
Liver Disease Treatment Market By Treatment Type Outlook (Revenue, USD Million, 2017 – 2030)
- Antiviral Drugs
- Immunosuppressants
- Vaccines
- Immunoglobulins
- Corticosteroids
- Targeted Therapy
- Chemotherapy
Liver Disease Treatment Market By Disease Type Outlook (Revenue, USD Million, 2017 – 2030)
- Hepatitis
- Autoimmune Diseases
- Non-alcoholic Fatty Liver Disease (NAFLD)
- Cancer
- Genetic Disorders
- Others
Liver Disease Treatment Market By Region Outlook (Revenue, USD Million, 2017 – 2030)
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Rest of Southeast Asia
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Liver Disease Treatment Market Report Scope |
| Report Attribute | Details |
| Market Size Value in 2022 | USD 21.43 billion |
| Revenue Forecast in 2030 | USD 33.14 billion |
| Growth Rate | CAGR of 5.6 % from 2023 to 2030 |
| Base Year for Estimation | 2022 |
| Historical Data | 2017 – 2022 |
| Forecast Years | 2023 – 2030 |
| Quantitative Units | Revenue in USD million and CAGR from 2023 to 2030 |
| Report Coverage | Revenue forecast, company ranking, Trends
competitive landscape, and growth factors |
| Segments Covered | Treatment Type, Disease Type, and Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico and Others |
| Key Companies Profiled | ABBVIE INC., ABBOTT LABORATORIES, ASTELLAS PHARMA INC., BRISTOL-MYERS SQUIBB, ELI LILLY AND COMPANY, EMERGENT BIOSOLUTIONS INC. (CANGENE BIOPHARMA), F. HOFFMANN-LA ROCHE AG, GILEAD SCIENCES, INC., MERCK & CO. INC, and VIATRIS INC. |
GLOBAL LIVER DISEASE TREATMENT MARKET ANALYSIS, 2017 – 2030
TABLE OF CONTENT
CHAPTER NO. 1: INTRODUCTION
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. USP & Key Offerings
1.2. Key Benefits for Stakeholders
1.3. Target Audience
1.4. Report Scope
CHAPTER NO. 2: EXECUTIVE SUMMARY
2.1. Liver Disease Treatment Market Snapshot
2.2. Global Liver Disease Treatment Market, 2017 – 2022 (USD Million)
2.1. Insights from Primary Respondents
CHAPTER NO. 3: COVID-19 IMPACT ANALYSIS
3.1. Impact Assessment of COVID-19 Pandemic, By Region
CHAPTER NO. 4: LIVER DISEASE TREATMENT MARKET – BY TREATMENT TYPE SEGMENT ANALYSIS
4.1. Liver Disease Treatment Market Overview, by Treatment Type Segment
4.1.1. Liver Disease Treatment Market Revenue Share, By Treatment Type, 2022 & 2030
4.2. Antiviral Drugs
4.2.1. Global Antiviral Drugs Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
4.3. Immunosuppressants
4.3.1. Global Immunosuppressants Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
4.4. Vaccines
4.4.1. Global Vaccines Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
4.5. Immunoglobulins
4.5.1. Global Immunoglobulins Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
4.6. Others
4.6.1. Global Others Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
CHAPTER NO. 5: LIVER DISEASE TREATMENT MARKET – BY DISEASE TYPE SEGMENT ANALYSIS
5.1. Liver Disease Treatment Market Overview, by Disease Type Segment
5.1.1. Liver Disease Treatment Market Revenue Share, By Disease Type, 2022 & 2030
5.2. Hepatitis
5.2.1. Global Liver Disease Treatment for Hepatitis Market Revenue, By Region, 2017 – 2022 (USD Million)
5.3. Autoimmune Diseases
5.3.1. Global Liver Disease Treatment for Autoimmune Diseases Market Revenue, By Region, 2017 – 2022 (USD Million)
5.4. Non-alcoholic Fatty Liver Disease (NAFLD)
5.4.1. Global Liver Disease Treatment for Non-alcoholic Fatty Liver Disease (NAFLD) Market Revenue, By Region, 2017 – 2022 (USD Million)
5.5. Cancer
5.5.1. Global Liver Disease Treatment for Cancer Market Revenue, By Region, 2017 – 2022 (USD Million)
5.6. Others
5.6.1. Global Liver Disease Treatment for Others Market Revenue, By Region, 2017 – 2022 (USD Million)
CHAPTER NO. 6: LIVER DISEASE TREATMENT MARKET – REGIONAL ANALYSIS
6.1. Liver Disease Treatment Market Overview, by Region Segment
6.1.1. Global Liver Disease Treatment Market Revenue Share, By Region, 2022 & 2030
6.1.2. Global Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
6.1.3. Global Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
6.1.4. Global Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
6.2. North America
6.2.1. North America Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
6.2.2. North America Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
6.2.3. North America Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico
6.3. Europe
6.3.1. Europe Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
6.3.2. Europe Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
6.3.3. Europe Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
6.3.4. UK
6.3.5. France
6.3.6. Germany
6.3.7. Italy
6.3.8. Spain
6.3.9. Russia
6.3.10. BENELUX
6.3.11. Sweden
6.3.12. Denmark
6.3.13. Poland
6.3.14. Austria
6.3.15. Rest of Europe
6.4. Asia Pacific
6.4.1. Asia Pacific Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
6.4.2. Asia Pacific Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
6.4.3. Asia Pacific Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
6.4.4. China
6.4.5. Japan
6.4.6. South Korea
6.4.7. India
6.4.8. Thailand
6.4.9. Indonesia
6.4.10. Vietnam
6.4.11. Malaysia
6.4.12. Philippines
6.4.13. Taiwan
6.4.14. Rest of Asia Pacific
6.5. Latin America
6.5.1. Latin America Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
6.5.2. Latin America Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
6.5.3. Latin America Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
6.5.4. Brazil
6.5.5. Argentina
6.5.6. Colombia
6.5.7. Chile
6.5.8. Peru
6.5.9. Rest of Latin America
6.6. The Middle-East
6.6.1. Middle East Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
6.6.2. Middle East Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
6.6.3. Middle East Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
6.6.4. GCC Countries
6.6.5. Israel
6.6.6. Turkey
6.6.7. Iran
6.6.8. Rest of Middle East & Africa
6.7. Africa
6.7.1. Africa Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
6.7.2. Africa Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
6.7.3. Africa Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
6.7.4. South Africa
6.7.5. Egypt
6.7.6. Nigeria
6.7.7. Algeria
6.7.8. Morocco
6.7.9. Rest of Africa
CHAPTER NO. 7: LIVER DISEASE TREATMENT MARKET – INDUSTRY ANALYSIS
7.1. Introduction
7.2. Market Drivers
7.2.1. Driving Factor 1 Analysis
7.2.2. Driving Factor 2 Analysis
7.3. Market Restraints
7.3.1. Restraining Factor Analysis
7.4. Market Opportunities
7.4.1. Market Opportunity Analysis
7.5. Porter’s Five Forces Analysis
7.6. Value Chain Analysis
CHAPTER NO. 8: KEY INVESTMENT POCKETS ANALYSIS
8.1. Top Investment Pockets
8.1.1.1. Liver Disease Treatment Market Attractiveness Analysis, By Treatment Type
8.1.1.2. Liver Disease Treatment Market Attractiveness Analysis, By Disease Type
8.1.1.3. Liver Disease Treatment Market Attractiveness Analysis, By End-user
8.2. Product Life Cycle Analysis
8.3. Incremental Revenue Growth Opportunity, 2023 – 2030
8.3.1. Treatment Type
8.3.2. Disease Type
CHAPTER NO. 9: ANALYSIS OF THE COMPETITIVE LANDSCAPE
9.1. Company Market Share Analysis – 2022
9.1.1. Global Liver Disease Treatment Market: Company Market Share, 2022
9.1. Global Liver Disease Treatment Market Company Market Share, 2022
9.2. Strategic Development
9.2.1. Acquisitions & Mergers
9.2.2. New Product Launch
9.2.3. Regional Expansion
CHAPTER NO. 10: COMPANY PROFILES
10.1. ABBVIE INC
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. ABBOTT LABORATORIES
10.3. ASTELLAS PHARMA INC.
10.4. BRISTOL-MYERS SQUIBB
10.5. ELI LILLY AND COMPANY
10.6. EMERGENT BIOSOLUTIONS INC. (CANGENE BIOPHARMA)
10.7. F. HOFFMANN-LA ROCHE AG
10.8. GILEAD SCIENCES INC.
10.9. MERCK & CO. INC
10.10. VIATRIS INC.
CHAPTER NO. 11: RESEARCH METHODOLOGY
11.1. Research Methodology
11.2. Phase I – Secondary Research
11.3. Phase II – Data Modeling
11.3.1. Company Share Analysis Model
11.3.2. Revenue-Based Modeling
11.4. Phase III – Primary Research
11.5. Research Limitations
11.5.1. Assumptions
List of Figures
FIG NO. 1. Global Liver Disease Treatment Market Revenue, 2017 – 2022 (USD Million)
FIG NO. 2. Liver Disease Treatment Market Revenue Share, By Treatment Type, 2022 & 2030
FIG NO. 3. Global Liver Disease Treatment Market for Antiviral Drugs, Revenue (USD Million) 2017 – 2030
FIG NO. 4. Global Liver Disease Treatment Market for Immunosuppressants, Revenue (USD Million) 2017 – 2030
FIG NO. 5. Global Liver Disease Treatment Market for Vaccines, Revenue (USD Million) 2017 – 2030
FIG NO. 6. Global Liver Disease Treatment Market for Immunoglobulins, Revenue (USD Million) 2017 – 2030
FIG NO. 7. Global Liver Disease Treatment Market for Others, Revenue (USD Million) 2017 – 2030
FIG NO. 8. Liver Disease Treatment Market Revenue Share, By Disease Type, 2022 & 2030
FIG NO. 9. Global Liver Disease Treatment Market for Hepatitis, Revenue (USD Million) 2017 – 2030
FIG NO. 10. Global Liver Disease Treatment Market for Autoimmune Diseases, Revenue (USD Million) 2017 – 2030
FIG NO. 11. Global Liver Disease Treatment Market for Non-alcoholic Fatty Liver Disease (NAFLD), Revenue (USD Million) 2017 – 2030
FIG NO. 12. Global Liver Disease Treatment Market for Cancer, Revenue (USD Million) 2017 – 2030
FIG NO. 13. Global Liver Disease Treatment Market for Others, Revenue (USD Million) 2017 – 2030
FIG NO. 14. Global Liver Disease Treatment Market Revenue Share, By Region, 2022 & 2030
FIG NO. 15. North America Liver Disease Treatment Market Revenue, 2017 – 2022 (USD Million)
FIG NO. 16. Europe Liver Disease Treatment Market Revenue, 2017 – 2022 (USD Million)
FIG NO. 17. Asia Pacific Liver Disease Treatment Market Revenue, 2017 – 2022 (USD Million)
FIG NO. 18. Latin America Liver Disease Treatment Market Revenue, 2017 – 2022 (USD Million)
FIG NO. 19. The Middle-East Liver Disease Treatment Market Revenue, 2017 – 2022 (USD Million)
FIG NO. 20. Africa Liver Disease Treatment Market Revenue, 2017 – 2022 (USD Million)
FIG NO. 21. Porter’s Five Forces Analysis for Global Liver Disease Treatment Market
FIG NO. 22. Value Chain Analysis for the Global Liver Disease Treatment Market
FIG NO. 23. Market Attractiveness Analysis, By Treatment Type
FIG NO. 24. Market Attractiveness Analysis, By Disease Type
FIG NO. 25. Market Attractiveness Analysis, By End-user
FIG NO. 26. Product Life Cycle Analysis
FIG NO. 27. Incremental Revenue Growth Opportunity by Treatment Type
FIG NO. 28. Incremental Revenue Growth Opportunity by Disease Type
FIG NO. 29. Company Share Analysis, 2022
FIG NO. 30. Liver Disease Treatment Market – Company Market Share, 2022
FIG NO. 31. Research Methodology – Detailed View
FIG NO. 32. Research Methodology
List of Tables
TABLE NO. 1. : Global Liver Disease Treatment Market: Snapshot
TABLE NO. 2. : Global Antiviral Drugs Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 3. : Global Antiviral Drugs Liver Disease Treatment Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 4. : Global Immunosuppressants Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 5. : Global Immunosuppressants Liver Disease Treatment Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 6. : Global Vaccines Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 7. : Global Vaccines Liver Disease Treatment Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 8. : Global Immunoglobulins Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 9. : Global Immunoglobulins Liver Disease Treatment Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 10. : Global Others Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 11. : Global Others Liver Disease Treatment Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 12. : Global Liver Disease Treatment for Hepatitis Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 13. : Global Liver Disease Treatment for Hepatitis Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 14. : Global Liver Disease Treatment for Autoimmune Diseases Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 15. : Global Liver Disease Treatment for Autoimmune Diseases Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 16. : Global Liver Disease Treatment for Non-alcoholic Fatty Liver Disease (NAFLD) Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 17. : Global Liver Disease Treatment for Non-alcoholic Fatty Liver Disease (NAFLD) Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 18. : Global Liver Disease Treatment for Cancer Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 19. : Global Liver Disease Treatment for Cancer Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 20. : Global Liver Disease Treatment for Others Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 21. : Global Liver Disease Treatment for Others Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 22. : Global Liver Disease Treatment Market Revenue, By Region, 2017 – 2022 (USD Million)
TABLE NO. 23. : Global Liver Disease Treatment Market Revenue, By Region, 2023– 2030 (USD Million)
TABLE NO. 24. : Global Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
TABLE NO. 25. : Global Liver Disease Treatment Market Revenue, By Treatment Type, 2023– 2030 (USD Million)
TABLE NO. 26. : Global Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
TABLE NO. 27. : Global Liver Disease Treatment Market Revenue, By Disease Type, 2023– 2030 (USD Million)
TABLE NO. 28. : North America Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
TABLE NO. 29. : North America Liver Disease Treatment Market Revenue, By Country, 2023– 2030 (USD Million)
TABLE NO. 30. : North America Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
TABLE NO. 31. : North America Liver Disease Treatment Market Revenue, By Treatment Type, 2023– 2030 (USD Million)
TABLE NO. 32. : North America Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
TABLE NO. 33. : North America Liver Disease Treatment Market Revenue, By Disease Type, 2023– 2030 (USD Million)
TABLE NO. 34. : Europe Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
TABLE NO. 35. : Europe Liver Disease Treatment Market Revenue, By Country, 2023– 2030 (USD Million)
TABLE NO. 36. : Europe Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
TABLE NO. 37. : Europe Liver Disease Treatment Market Revenue, By Treatment Type, 2023– 2030 (USD Million)
TABLE NO. 38. : Europe Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
TABLE NO. 39. : Europe Liver Disease Treatment Market Revenue, By Disease Type, 2023– 2030 (USD Million)
TABLE NO. 40. : Asia Pacific Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
TABLE NO. 41. : Asia Pacific Liver Disease Treatment Market Revenue, By Country, 2023– 2030 (USD Million)
TABLE NO. 42. : Asia Pacific Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
TABLE NO. 43. : Asia Pacific Liver Disease Treatment Market Revenue, By Treatment Type, 2023– 2030 (USD Million)
TABLE NO. 44. : Asia Pacific Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
TABLE NO. 45. : Asia Pacific Liver Disease Treatment Market Revenue, By Disease Type, 2023– 2030 (USD Million)
TABLE NO. 46. : Latin America Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
TABLE NO. 47. : Latin America Liver Disease Treatment Market Revenue, By Country, 2023– 2030 (USD Million)
TABLE NO. 48. : Latin America Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
TABLE NO. 49. : Latin America Liver Disease Treatment Market Revenue, By Treatment Type, 2023– 2030 (USD Million)
TABLE NO. 50. : Latin America Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
TABLE NO. 51. : Latin America Liver Disease Treatment Market Revenue, By Disease Type, 2023– 2030 (USD Million)
TABLE NO. 52. : Middle East Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
TABLE NO. 53. : Middle East Liver Disease Treatment Market Revenue, By Country, 2023– 2030 (USD Million)
TABLE NO. 54. : Middle East Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
TABLE NO. 55. : Middle East Liver Disease Treatment Market Revenue, By Treatment Type, 2023– 2030 (USD Million)
TABLE NO. 56. : Middle East Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
TABLE NO. 57. : Middle East Liver Disease Treatment Market Revenue, By Disease Type, 2023– 2030 (USD Million)
TABLE NO. 58. : Africa Liver Disease Treatment Market Revenue, By Country, 2017 – 2022 (USD Million)
TABLE NO. 59. : Africa Liver Disease Treatment Market Revenue, By Country, 2023– 2030 (USD Million)
TABLE NO. 60. : Africa Liver Disease Treatment Market Revenue, By Treatment Type, 2017 – 2022 (USD Million)
TABLE NO. 61. : Africa Liver Disease Treatment Market Revenue, By Treatment Type, 2023– 2030 (USD Million)
TABLE NO. 62. : Africa Liver Disease Treatment Market Revenue, By Disease Type, 2017 – 2022 (USD Million)
TABLE NO. 63. : Africa Liver Disease Treatment Market Revenue, By Disease Type, 2023– 2030 (USD Million)
TABLE NO. 64. : Drivers for the Liver Disease Treatment Market: Impact Analysis
TABLE NO. 65. : Restraints for the Liver Disease Treatment Market: Impact Analysis
